In particular, the recent study showed a high incidence of MYD88 (13%) and KMT2D (11%) mutations in Chinese patients with CLL [30], while a considerably higher incidence of MYD88 mutations (28%) was observed in our cohort of Korean CLL patients. This evidence concerns the gene MYD88 and B-cell chronic lymphocytic leukemia.